Hydrodissection-Assisted Bipolar Prostatic Enucleation-Enucleoresection With Subcapsular Injection of Diluted Norepinephrine-Methylene Blue Mixture Versus Conventional Bipolar Prostatic Enucleation-Enucleoresection: A Prospective Randomized Comparative Study (2026)

Government Record · Saad ali saad salama (principal investigator), Benha University · August 2026

Saad ali saad salama (principal investigator), 2026-08: Registered (not yet recruiting) randomised trial comparing hydrodissection-assisted bipolar prostatic enucleation with subcapsular injection of diluted norepinephrine plus methylene blue against conventional bipolar enucleation in 100 men with BPH; primary outcome intraoperative blood loss.

Participants will be assigned to either hydrodissection-assisted bipolar prostatic enucleation-enucleoresection with transrectal ultrasound-guided subcapsular injection of diluted norepinephrine and methylene blue or conventional bipolar prostatic enucleation-enucleoresection without injection.

Saad ali saad salama (principal investigator), 2026-08: Registered (not yet recruiting) randomised trial comparing hydrodissection-assisted bipolar prostatic enucleation with subcapsular injection of diluted norepinephrine plus methylene blue against conventional bipolar enucleation in 100 men with BPH; primary outcome intraoperative blood loss. C4 (also C5, C10). Study type: prospective randomised comparative trial, registered, NOT_YET_RECRUITING (estimated start 2026-08-15). N: 100 planned. Country: Egypt (Benha University). Methylene blue: diluted, mixed with norepinephrine, injected into the subcapsular plane under transrectal ultrasound guidance; concentration and volume not stated in the record. Funders/conflicts: not stated. Comparator: conventional bipolar enucleation without injection. Quote is a record field from api/v2/studies/NCT07749794. Registered, no results posted. Also filed as MTN-29 (claims C4, C5).